Amphastar Pharmaceuticals Q3 2022 Earnings Preview

Nov. 07, 2022 12:40 AM ETAmphastar Pharmaceuticals, Inc. (AMPH)By: Gaurav Batavia, SA News Editor
  • Amphastar Pharmaceuticals (NASDAQ:AMPH) is scheduled to announce Q3 earnings results on Monday, November 7th, after market close.
  • The consensus EPS Estimate is $0.39 (-15.2% Y/Y) and the consensus Revenue Estimate is $126.4M (+12.7% Y/Y).
  • Over the last 2 years, AMPH has beaten EPS estimates 100% of the time and has beaten revenue estimates 88% of the time.
  • Over the last 3 months, EPS estimates have seen 2 upward revisions and 3 downward. Revenue estimates have seen 1 upward revision and 2 downward.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.